Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News The Spectranetics Corporation SPNC

"The Spectranetics Corp manufactures and sells single-use medical devices which are used to cross, prepare, and treat arterial blockages in the legs and heart and to remove pacemaker and defibrillator cardiac leads."

Recent & Breaking News (NDAQ:SPNC)

Spectranetics to Participate in Upcoming Investor Conferences

Globe Newswire August 26, 2013

Kimberly Bridges Named to Lead Vascular Intervention Business Unit at Spectranetics

Globe Newswire August 22, 2013

Spectranetics Broadens Laser Catheter Portfolio to Treat Complex Lesions and Chronic Total Occlusions (CTOs)

Globe Newswire August 19, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on JAKK, MRVL, SPNC and WU

Accesswire August 15, 2013

Spectranetics to Participate in Upcoming Conferences

Globe Newswire July 29, 2013

Spectranetics Achieves Second Quarter Revenue of $39.5 Million

Globe Newswire July 24, 2013

Spectranetics to Hold 2013 Second Quarter Financial Results Conference Call on July 24

Globe Newswire July 11, 2013

Spectranetics Finalizes EXCITE ISR Adjunct Analysis Plan

Globe Newswire May 6, 2013

Spectranetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Over-Allotment Option

Globe Newswire May 1, 2013

Spectranetics Prices Public Offering of Common Stock

Globe Newswire April 25, 2013

Spectranetics Announces Common Stock Offering

Globe Newswire April 23, 2013

Spectranetics Achieves First Quarter Revenue of $37.7 Million

Globe Newswire April 23, 2013

Spectranetics to Hold 2013 First Quarter Financial Results Conference Call on April 23

Globe Newswire April 11, 2013

Spectranetics Achieves Fourth Quarter Revenue of $36.8 Million

Troy Schwensen February 21, 2013

Spectranetics to Participate in the Citi 2013 Global Healthcare Conference

Troy Schwensen February 19, 2013

Spectranetics Announces Expansion Into Japan Peripheral Intervention Market

Troy Schwensen January 29, 2013

Spectranetics to Hold 2012 Fourth Quarter Financial Results Conference Call on February 21

Troy Schwensen January 28, 2013

Final Results of Spectranetics Study Supports Successful Use of Laser Atherectomy for Treating Patients With Peripheral In-Stent Restenosis

Troy Schwensen January 24, 2013

The Spectranetics Corporation Strengthens Vascular Portfolio With Purchase of Upstream Peripheral Technologies, Ltd

Troy Schwensen January 7, 2013

Spectranetics to Present at the 31st Annual J.P. Morgan Healthcare Conference

Troy Schwensen December 27, 2012